When Joe Biden toured Pfizer’s Covid-19 vaccine manufacturing plant in Kalamazoo, Michigan, earlier this year, his visit appeared to mark a thaw in relations between Washington and large pharmaceutical companies.
“I wanted to come here, Albert, to thank you and to thank all the workers here,” the US president told Albert Bourla, Pfizer’s chief executive, in February.
Weeks later, Bourla was being given a dressing down by Katherine Tai, the US trade representative, during a call to discuss whether the administration should back a move to suspend intellectual property rights for Covid-19 vaccines.
您已阅读8%（602字），剩余92%（7182字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。